[go: up one dir, main page]

AR241942A1 - Procedimiento para preparar una proteina que tiene uno o mas determinantes inmuno-reactivos y/o antigenos de un antigeno de superficie eimeria, procedimientos y productos relacionados. - Google Patents

Procedimiento para preparar una proteina que tiene uno o mas determinantes inmuno-reactivos y/o antigenos de un antigeno de superficie eimeria, procedimientos y productos relacionados.

Info

Publication number
AR241942A1
AR241942A1 AR89314066A AR31406689A AR241942A1 AR 241942 A1 AR241942 A1 AR 241942A1 AR 89314066 A AR89314066 A AR 89314066A AR 31406689 A AR31406689 A AR 31406689A AR 241942 A1 AR241942 A1 AR 241942A1
Authority
AR
Argentina
Prior art keywords
coccidiosis vaccines
recombinant
recombinant coccidiosis
vaccines
coccidiosis
Prior art date
Application number
AR89314066A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR241942A1 publication Critical patent/AR241942A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AR89314066A 1988-06-03 1989-06-01 Procedimiento para preparar una proteina que tiene uno o mas determinantes inmuno-reactivos y/o antigenos de un antigeno de superficie eimeria, procedimientos y productos relacionados. AR241942A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20272188A 1988-06-03 1988-06-03

Publications (1)

Publication Number Publication Date
AR241942A1 true AR241942A1 (es) 1993-01-29

Family

ID=22750986

Family Applications (1)

Application Number Title Priority Date Filing Date
AR89314066A AR241942A1 (es) 1988-06-03 1989-06-01 Procedimiento para preparar una proteina que tiene uno o mas determinantes inmuno-reactivos y/o antigenos de un antigeno de superficie eimeria, procedimientos y productos relacionados.

Country Status (22)

Country Link
US (2) US5661015A (es)
EP (1) EP0344808B1 (es)
JP (1) JP3051130B2 (es)
KR (1) KR0156545B1 (es)
CN (3) CN1040126C (es)
AR (1) AR241942A1 (es)
AT (1) ATE120489T1 (es)
AU (1) AU635704B2 (es)
CA (1) CA1340538C (es)
DE (1) DE68921923T2 (es)
DK (1) DK272889A (es)
ES (1) ES2070866T3 (es)
FI (1) FI101453B (es)
HU (1) HU212505B (es)
IE (1) IE67544B1 (es)
IL (1) IL90489A0 (es)
MC (1) MC2039A1 (es)
NO (1) NO303876B1 (es)
NZ (1) NZ229377A (es)
PT (1) PT90727B (es)
YU (1) YU47880B (es)
ZA (1) ZA893740B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5174993A (en) * 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US5279960A (en) * 1984-07-05 1994-01-18 Enzon Corp. 25 KD coccidial antigen of eimeria tenella
US5273901A (en) * 1984-07-05 1993-12-28 Enzon Corp. Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
US5824656A (en) * 1988-01-15 1998-10-20 Merck & Co., Inc. Recombinant and native group B eimeria tenella immunogens useful as coccidiosis vaccines
EP0432168B1 (en) * 1988-07-05 1996-10-16 British Technology Group Usa Inc Genetically engineered coccidiosis vaccine
ZA902147B (en) * 1989-03-28 1990-12-28 Akzo Nv Coccidiosis vaccine
EP0403698B1 (en) * 1989-06-21 1993-09-08 Akzo Nobel N.V. Eimeria tenella vaccine
ZA9010461B (en) * 1990-01-26 1991-10-30 Hoffmann La Roche Recombinant coccidiosis vaccines-5-7 eimeria surface antigen
DK0575317T3 (da) * 1991-03-14 1996-12-09 British Tech Group Usa Rekombinant anticoccidie-vaccine
US6008342A (en) * 1991-07-12 1999-12-28 Roche Vitamins Inc. DNA encoding eimeria antigen
US5403581A (en) * 1991-07-12 1995-04-04 Hoffmann-La Roche Inc. Coccidiosis vaccines
SK282436B6 (sk) 1995-06-07 2002-02-05 Pfizer Inc. Živé sporocysty alebo oocysty Eimeria alebo ich zmesi na výrobu očkovacej látky
EP0831897B1 (en) 1995-06-07 2001-03-28 Pfizer Inc. In ovo vaccination against coccidiosis
DE69635472T2 (de) * 1995-07-03 2006-04-13 Akzo Nobel N.V. Impfstoff gegen Geflügelkokzidose
AU2590997A (en) * 1996-03-29 1997-10-22 Life Technologies, Inc. Method for increasing viability and transformation efficiency of bacteria during storage at low temperatures
US6632923B1 (en) * 1996-11-27 2003-10-14 Boston Heart Foundation, Inc. Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
NZ500033A (en) * 1998-10-07 2001-06-29 Akzo Nobel Nv Hydrophilic eimeria polypeptides for use as coccidiosis vaccines
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
ZA200400479B (en) * 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
KR100490669B1 (ko) * 2001-08-30 2005-05-19 (주)아비코아생명공학연구소 조류 콕시듐증을 유발하는 에이메리아 종의 포자소체 표면항원에 대한 ｓｃＦｖ 재조합 항체
ES2351299T3 (es) 2001-08-30 2011-02-02 Embrex, Inc. Procedimientos mejorados para la producción de ooquistes.
JP3995541B2 (ja) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション 抗鶏コクシジウム症組成物
DE10330235A1 (de) * 2003-07-04 2005-01-20 Bayer Healthcare Ag Neues Eimeria Gen und Protein sowie deren Verwendung
US7348401B2 (en) * 2003-09-10 2008-03-25 Innate Biotech, Inc. Peptides that inhibit complement activation
EP1742656B1 (en) * 2004-03-12 2010-06-16 University Of Georgia Research Foundation, Inc. Novel peanut skin extract as a vaccine adjuvant
US7087425B2 (en) * 2004-03-31 2006-08-08 Embrex, Inc. Method of purifying oocysts using enzymatic digestion of fecal debris
US20110078828A1 (en) * 2004-09-10 2011-03-31 Guardian Biotechnologies Inc. Multi epitope vaccine for poultry
EP1666489B1 (en) * 2004-12-01 2007-11-21 Zeon Corporation DNA encoding an antigenic protein of eimeria apical membrane antigen 1 and use thereof
CN100398156C (zh) * 2005-11-23 2008-07-02 南京农业大学 用于预防鸡球虫病的免疫调节型dna疫苗
US20080194006A1 (en) * 2007-02-08 2008-08-14 Embrex, Inc. Methods of releasing sporocysts from oocysts using controlled shear forces
US11701683B2 (en) 2010-12-22 2023-07-18 The Procter & Gamble Company Methods for foil stamping parts having asymmetrical edges
WO2018115229A1 (en) 2016-12-22 2018-06-28 Intervet International B.V. Eimeria vaccine with improved efficacy
EP3976816A4 (en) * 2019-05-28 2023-10-25 Case Western Reserve University COMPOSITIONS AND METHODS FOR PRESERVING DNA METHYLATION
EP4158016A4 (en) 2020-05-27 2024-06-05 Case Western Reserve University COMPOSITIONS AND METHODS FOR PRESERVING DNA METHYLATION

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
DE2814039C3 (de) 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
EP0135712A3 (en) * 1983-08-19 1987-05-27 American Cyanamid Company Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp.
US4650676A (en) 1983-08-19 1987-03-17 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozoites of Eimeria spp.
EP0135073A3 (en) * 1983-08-19 1987-05-27 American Cyanamid Company Antigens and monoclonal antibodies reactive against merozites of eimeria spp.
US4710377A (en) * 1983-08-19 1987-12-01 American Cyanamid Company Antigens and monoclonal antibodies reactive against sporozoites of Eimeria spp.
CA1340520C (en) * 1984-06-05 1999-05-04 Karel Z. Newman Jr. Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix
US5187080A (en) * 1984-06-05 1993-02-16 Solvay & Cie S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US4874705A (en) * 1985-05-16 1989-10-17 Solvay & Cie, S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
US4639372A (en) * 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US5273901A (en) * 1984-07-05 1993-12-28 Enzon Corp. Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
EP0190254A4 (en) * 1984-07-05 1987-03-09 Genex Corp GENE CLONE AND PROCESS FOR THE PREPARATION AND USE THEREOF.
DE3650540T2 (de) * 1985-12-03 1997-02-27 Solvay Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
EP0241139A3 (en) * 1986-03-13 1989-04-19 Merck & Co. Inc. Anti-idiotypic vaccine for coccidiosis
US5496550A (en) * 1986-08-14 1996-03-05 Chilwalner Method of reducing the output of Eimeria oocysts from a newborn chick
DE3855665D1 (de) * 1987-03-06 1996-12-19 Amgen Boulder Inc Polypeptide zur verwendung bei der diagnose von kokkidien-infektion und rekombinant-dns, verfahren zur herstellung derselben
EP0315073A2 (en) * 1987-11-02 1989-05-10 Matsushita Electric Industrial Co., Ltd. A composition for pattern forming materials
NZ227595A (en) * 1988-01-15 1991-11-26 Merck & Co Inc Recombinant production of eimeria tenella antigens and their use
NZ227597A (en) * 1988-01-15 1991-11-26 Merck & Co Inc Eimeria tenella group b immunogens and their production
AU620366B2 (en) * 1988-02-12 1992-02-20 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated response and method of producing the same
DE3926461A1 (de) * 1989-07-15 1991-01-24 Suttner Gmbh & Co Kg Ventilpistole, insbesondere fuer ein hochdruckreinigungsgeraet

Also Published As

Publication number Publication date
ATE120489T1 (de) 1995-04-15
AU635704B2 (en) 1993-04-01
FI101453B1 (fi) 1998-06-30
PT90727A (pt) 1989-12-29
NO892251D0 (no) 1989-06-02
NO892251L (no) 1989-12-04
MC2039A1 (fr) 1990-05-30
FI101453B (fi) 1998-06-30
CA1340538C (en) 1999-05-11
EP0344808A1 (en) 1989-12-06
YU47880B (sh) 1996-05-20
CN1186695A (zh) 1998-07-08
HUT52963A (en) 1990-09-28
IE67544B1 (en) 1996-04-17
HU212505B (en) 1996-07-29
KR910000183A (ko) 1991-01-29
DK272889A (da) 1989-12-04
KR0156545B1 (ko) 1998-11-16
IL90489A0 (en) 1990-01-18
CN1187368A (zh) 1998-07-15
US20030175311A1 (en) 2003-09-18
CN1040126C (zh) 1998-10-07
FI892714L (fi) 1989-12-04
YU113889A (en) 1991-10-31
EP0344808B1 (en) 1995-03-29
IE891812L (en) 1989-12-03
PT90727B (pt) 1994-11-30
FI892714A0 (fi) 1989-06-02
CN1077438C (zh) 2002-01-09
NZ229377A (en) 1992-06-25
ZA893740B (en) 1990-02-28
CN1076204C (zh) 2001-12-19
JP3051130B2 (ja) 2000-06-12
DE68921923D1 (de) 1995-05-04
US5661015A (en) 1997-08-26
CN1038837A (zh) 1990-01-17
AU3601689A (en) 1989-12-07
NO303876B1 (no) 1998-09-14
ES2070866T3 (es) 1995-06-16
DE68921923T2 (de) 1995-08-10
DK272889D0 (da) 1989-06-02
JPH037594A (ja) 1991-01-14

Similar Documents

Publication Publication Date Title
AR241942A1 (es) Procedimiento para preparar una proteina que tiene uno o mas determinantes inmuno-reactivos y/o antigenos de un antigeno de superficie eimeria, procedimientos y productos relacionados.
EP0256878A3 (en) Vaccines
EP0391997A4 (en) Vaccine
ZA902147B (en) Coccidiosis vaccine
KR970007376B1 (en) Coccidiosis vaccine
ZA88149B (en) Anti-reproductive vaccines
GB8921470D0 (en) Vaccines
ZA925103B (en) Coccidiosis vaccines
EP0324648A3 (en) Recombinant eimeria tenella vaccines
KR960016703B1 (en) Recombinant avipoxvirus
IL90833A0 (en) Immunogenic peptide
GB8615068D0 (en) Vaccines
GB2222165B (en) Recombinant capripoxvirus
GB8912496D0 (en) Vaccines
ZA89289B (en) Recombinant eimeria tenella vaccines
GB8804688D0 (en) Vaccines
IE880831L (en) Vaccines
GB8810807D0 (en) Vaccines
GB8605646D0 (en) Vaccines
GB8828523D0 (en) St-lt recombinant antigen vaccines
GB8805603D0 (en) Vaccine
IE882054L (en) Vaccine
ZA882001B (en) Vaccines
GB8712829D0 (en) Vaccines
GB8716632D0 (en) Vaccines